Photodynamic therapy for Barretts’ adenocarcinoma associated with an Angelchik device
✍ Scribed by John T. Jenkins; Arlette Charles; Kenneth G. Mitchell; Grant M. Fullarton
- Book ID
- 119625072
- Publisher
- Elsevier Science
- Year
- 2005
- Tongue
- English
- Weight
- 168 KB
- Volume
- 2
- Category
- Article
- ISSN
- 1572-1000
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Background and Objectives: Photodynamic therapy (PDT) with porfimer sodium, FDA approved to treat premalignant lesions in Barrett's esophagus, causes photosensitivity for 6-8 weeks. HPPH (2-[1-hexyloxyethyl]-2devinyl pyropheophorbide-a) shows minimal photosensitization of short duration and promisin
## Abstract ## Background and Objectives Surgical excision of primary nasopharyngeal papillary adenocarcinoma is sometimes incomplete with remaining microscopic disease. Post‐operative radiotherapy only has limited efficacy but may cause many complications. ## Study Design/Materials and Methods